Psychological engagement through virtual reality

This entry describes a psychological construct and therapeutic outcome, not a molecular target suitable for drug development. 'Psychological engagement through virtual reality' refers to the subjective experiences of presence (feeling of "being there" in the virtual environment) and embodiment (sense of body ownership) that Virtual Reality (VR) technology can produce. These are behavioral and cognitive phenomena, and outcomes of VR interventions, rather than a protein, receptor, ion channel, enzyme, transporter, or other molecular entity that can be directly modulated by a drug. Therefore, it is not a recognized molecular entity and cannot be classified as a drug target in the context of pharmaceutical/biotechnology terminology. If the intent is to identify actual drug targets for mental health conditions that VR interventions address, those would involve specific receptors and neurotransmitter systems (e.g., serotonin receptors, GABA receptors), not the concept of 'psychological engagement' itself.